Clinical Trial: A First-in-human Phase 1 Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants

U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07662057) titled 'A First-in-human Phase 1 Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants' on June 18.

Brief Summary: The purpose of this study is assess the safety and tolerability of AB102 and characterize the pharmacokinetics (PK) profile of AB102 after single and multiple ascending oral dose(s).

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: AB102

Administered orally as specified in the treatment arm

OTHER: Placebo

Administered orally as specified in the treatment arm

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Arcus Biosciences, Inc....